|
|
| |
|
| |
| |
|
| |
Intellectual Property Strategy
With continued reproducible R & D success, Bioved has recently adopted an
aggressive IP Strategy in filing US, India and International patents for its
proprietary natural products and technologies. We currently have three issued
patents and three applications. A similar approach to publications in reputed
peer-reviewed medical journals is underway. These services can be expanded and
offered to meet the needs of our clients and partner companies.
Bioved is focused on the discovery and development of natural products for 'Disorders of the Aging Population' that have treatment limitations in modern medicine. Having a well documented 4,000 year old science of Ayurveda, and leveraged cost-effective R & D in India gives the Company an advantage to rapidly screen, define, develop and test natural products that meet the needs of regulatory bodies, consumers and markets worldwide. The Company still does the entire spectrum of N/Rx validation, but with the confidence of Ayurvedic medicine, some of these activities can be done in parallel, rather than sequentially, to significantly reduce both the development time and the cost.
BV-9238 - Inflammatory Bowel Disease
BV-9211 - Osteoporosis
BV-3111 - Immune Health
BV-4231 - Metabolic Syndrome
|
|
|
|